NCT02637622View on ClinicalTrials.gov

Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment

CompletedOBSERVATIONAL
Enrollment

1,103

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

February 28, 2017

Conditions
Type II Diabetes
Interventions
OTHER

Best-Worst Scaling (Case 2)

Respondents receive questions asking them to choose the best and worst features of a hypothetical medication.

OTHER

Discrete Choice Experiment

Respondents receive questions asking them to choose the medication they prefer between a pair of hypothetical medications.

Trial Locations (1)

21205

Johns Hopkins Bloomberg School of Public Health, Baltimore

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT02637622 - Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment | Biotech Hunter | Biotech Hunter